BHVN
Allianz Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-183,768
| Closed | -$27.8M | – | 1598 |
|
|
2022
Q3 | $27.8M | Sell |
183,768
-51,300
| -22% | -$7.75M | 0.06% | 334 |
|
|
2022
Q2 | $34.3M | Buy |
235,068
+162,825
| +225% | +$23.7M | 0.03% | 502 |
|
|
2022
Q1 | $8.57M | Buy |
72,243
+10
| +0% | +$1.19K | 0.01% | 952 |
|
|
2021
Q4 | $9.96M | Sell |
72,233
-17,117
| -19% | -$2.36M | 0.01% | 929 |
|
|
2021
Q3 | $12.4M | Buy |
89,350
+41,748
| +88% | +$5.8M | 0.01% | 836 |
|
|
2021
Q2 | $4.62M | Buy |
47,602
+16,663
| +54% | +$1.62M | ﹤0.01% | 1053 |
|
|
2021
Q1 | $2.11M | Buy |
30,939
+6,977
| +29% | +$477K | ﹤0.01% | 1252 |
|
|
2020
Q4 | $2.05M | Buy |
+23,962
| New | +$2.05M | ﹤0.01% | 1291 |
|
|
2020
Q1 | – | Sell |
-8,820
| Closed | -$481K | – | 2326 |
|
|
2019
Q4 | $481K | Sell |
8,820
-5,064
| -36% | -$276K | ﹤0.01% | 1928 |
|
|
2019
Q3 | $579K | Sell |
13,884
-58,230
| -81% | -$2.43M | ﹤0.01% | 1847 |
|
|
2019
Q2 | $3.16M | Buy |
72,114
+11,560
| +19% | +$506K | ﹤0.01% | 1394 |
|
|
2019
Q1 | $3.12M | Sell |
60,554
-469
| -0.8% | -$24.1K | ﹤0.01% | 1411 |
|
|
2018
Q4 | $2.26M | Buy |
+61,023
| New | +$2.26M | ﹤0.01% | 1437 |
|